UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Left Ventricular Assist Device Design Reduces von Willebrand Factor Degradation: A Comparative Study Between the HeartMate II and the EVAHEART Left Ventricular Assist System

The Annals of thoracic surgery, 2017-04, Vol.103 (4), p.1239-1244

2017

Volltextzugriff (PDF)

Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: Mechanical demolition and enzymatic cleavage

The Journal of thoracic and cardiovascular surgery, 2015, Vol.149 (1), p.281-289

2015

Volltextzugriff (PDF)

Toward a Standard Practice to Quantify von Willebrand Factor Degradation During Left Ventricular Assist Device Support

The Annals of thoracic surgery, 2021-10, Vol.112 (4), p.1257-1264

2021

Volltextzugriff (PDF)

Continuous-Flow LVAD Support Causes a Distinct Form of Intestinal Angiodysplasia

Circulation research, 2017-09, Vol.121 (8), p.963-969

2017

Volltextzugriff (PDF)

Decreased RPM reduces von Willebrand factor degradation with the EVAHEART LVAS: implications for device‐specific LVAD management

Journal of cardiac surgery, 2020-07, Vol.35 (7), p.1477-1483

2020

Volltextzugriff (PDF)

Patient-specific severity of von Willebrand factor degradation identifies patients with a left ventricular assist device at high risk for bleeding

The Journal of thoracic and cardiovascular surgery, 2024-01, Vol.167 (1), p.196-204

2024

Volltextzugriff (PDF)

Pathologic von Willebrand factor degradation is a major contributor to left ventricular assist device-associated bleeding: pathophysiology and evolving clinical management

Annals of cardiothoracic surgery, 2021-05, Vol.10 (3), p.389-392

Bartoli, Carlo R.

2021

Volltextzugriff (PDF)

A Novel Toroidal-Flow Left Ventricular Assist Device Minimizes Blood Trauma: Implications of Improved Ventricular Assist Device Hemocompatibility

The Annals of thoracic surgery, 2019-06, Vol.107 (6), p.1761-1767

2019

Volltextzugriff (PDF)

Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation

The Journal of thoracic and cardiovascular surgery, 2016-06, Vol.151 (6), p.1747-1754.e1

2016

Volltextzugriff (PDF)

Multi-Objective Optimization of HVAC Operation for Balancing Energy Use and Occupant Comfort in Educational Buildings

Energies (Basel), 2021-05, Vol.14 (10), p.2847

2021

Volltextzugriff (PDF)

Experimental Analysis of an Air Heat Pump for Heating Service Using a “Hardware-In-The-Loop” System

Energies (Basel), 2020-09, Vol.13 (17), p.4498

2020

Volltextzugriff (PDF)

Hemodynamic Support With a Microaxial Percutaneous Left Ventricular Assist Device (Impella) Protects Against Acute Kidney Injury in Patients Undergoing High-Risk Percutaneous Coronary Intervention

Circulation research, 2017-02, Vol.120 (4), p.692-700

2017

Volltextzugriff (PDF)

Clinical and In Vitro Evidence That Subclinical Hemolysis Contributes to LVAD Thrombosis

The Annals of thoracic surgery, 2018-03, Vol.105 (3), p.807-814

2018

Volltextzugriff (PDF)

Impact of hepatopulmonary syndrome in liver transplantation candidates and the role of angiogenesis

The European respiratory journal, 2022-08, Vol.60 (2), p.2102304

2022

Volltextzugriff (PDF)

Do patients with a continuous-flow left ventricular assist device benefit from induced-pulsatility or are we just spinning our wheels?

The Journal of thoracic and cardiovascular surgery, 2015-10, Vol.150 (4), p.945-946

2015

Volltextzugriff (PDF)

Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis

Circulation. Heart failure, 2018-09, Vol.11 (9), p.e004638-e004638

2018

Volltextzugriff (PDF)

Optimized Energy and Air Quality Management of Shared Smart Buildings in the COVID-19 Scenario

Energies (Basel), 2021-04, Vol.14 (8), p.2124

2021

Volltextzugriff (PDF)

COMPETENCE Trial: The EVAHEART 2 continuous flow left ventricular assist device

The Journal of heart and lung transplantation, 2023-01, Vol.42 (1), p.33-39

2023

Volltextzugriff (PDF)

Contralateral Thoracotomy With Extracorporeal Circulation for Reoperative Resection of a Kommerell Diverticulum

World journal for pediatric & congenital heart surgery, 2024-03, Vol.15 (2), p.242-245

2024

Volltextzugriff (PDF)

Predictors and clinical impact of pre-existing and acquired thrombocytopenia following transcatheter aortic valve replacement

Catheterization and cardiovascular interventions, 2015-01, Vol.85 (1), p.118-129

2015

Volltextzugriff (PDF)

Mechanistic Pathway(s) of Acquired Von Willebrand Syndrome with a Continuous-Flow Ventricular Assist Device: In Vitro Findings

ASAIO journal (1992), 2013-03, Vol.59 (2), p.123-129

2013

Volltextzugriff (PDF)

Diagnosis, Nonsurgical Management, and Prevention of LVAD Thrombosis

Journal of cardiac surgery, 2014-01, Vol.29 (1), p.83-94

2014

Volltextzugriff (PDF)

Kinetic and Dynamic Effects on Degradation of von Willebrand Factor

ASAIO journal (1992), 2023-05, Vol.69 (5), p.467-474

2023

Volltextzugriff (PDF)

Insights into the mechanism(s) of von Willebrand factor degradation during mechanical circulatory support

The Journal of thoracic and cardiovascular surgery, 2014-05, Vol.147 (5), p.1634-1643

2014

Volltextzugriff (PDF)

Ultrasounds Used as Promoters of Heat-Transfer Enhancement of Natural Convection in Dielectric Fluids for the Thermal Control of Electronic Equipment

Acoustics (Basel, Switzerland), 2020-06, Vol.2 (2), p.279-292

2020

Volltextzugriff (PDF)

1 – 25 von 274

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(252)
Mit Volltextzugriff
(246)

Publikationsform

Sprache

Englisch
(272)
Italienisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Left Ventricular Assist Device Design Reduces von Willebrand Factor Degradation: A Comparative Study Between the HeartMate II and the EVAHEART Left Ventricular Assist System

Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: Mechanical demolition and enzymatic cleavage

Toward a Standard Practice to Quantify von Willebrand Factor Degradation During Left Ventricular Assist Device Support

Continuous-Flow LVAD Support Causes a Distinct Form of Intestinal Angiodysplasia

Decreased RPM reduces von Willebrand factor degradation with the EVAHEART LVAS: implications for device‐specific LVAD management

Patient-specific severity of von Willebrand factor degradation identifies patients with a left ventricular assist device at high risk for bleeding

Pathologic von Willebrand factor degradation is a major contributor to left ventricular assist device-associated bleeding: pathophysiology and evolving clinical management

A Novel Toroidal-Flow Left Ventricular Assist Device Minimizes Blood Trauma: Implications of Improved Ventricular Assist Device Hemocompatibility

Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation

Multi-Objective Optimization of HVAC Operation for Balancing Energy Use and Occupant Comfort in Educational Buildings

Experimental Analysis of an Air Heat Pump for Heating Service Using a “Hardware-In-The-Loop” System

Hemodynamic Support With a Microaxial Percutaneous Left Ventricular Assist Device (Impella) Protects Against Acute Kidney Injury in Patients Undergoing High-Risk Percutaneous Coronary Intervention

Clinical and In Vitro Evidence That Subclinical Hemolysis Contributes to LVAD Thrombosis

Impact of hepatopulmonary syndrome in liver transplantation candidates and the role of angiogenesis

Do patients with a continuous-flow left ventricular assist device benefit from induced-pulsatility or are we just spinning our wheels?

Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis

Optimized Energy and Air Quality Management of Shared Smart Buildings in the COVID-19 Scenario

COMPETENCE Trial: The EVAHEART 2 continuous flow left ventricular assist device

Contralateral Thoracotomy With Extracorporeal Circulation for Reoperative Resection of a Kommerell Diverticulum

Predictors and clinical impact of pre-existing and acquired thrombocytopenia following transcatheter aortic valve replacement

Mechanistic Pathway(s) of Acquired Von Willebrand Syndrome with a Continuous-Flow Ventricular Assist Device: In Vitro Findings

Diagnosis, Nonsurgical Management, and Prevention of LVAD Thrombosis

Kinetic and Dynamic Effects on Degradation of von Willebrand Factor

Insights into the mechanism(s) of von Willebrand factor degradation during mechanical circulatory support

Ultrasounds Used as Promoters of Heat-Transfer Enhancement of Natural Convection in Dielectric Fluids for the Thermal Control of Electronic Equipment

Suchergebnisse filtern